Eli Lilly and Company
A global pharmaceutical company headquartered in Indianapolis, Indiana.
Founded in 1876 by Colonel Eli Lilly, Eli Lilly and Company is a global pharmaceutical leader with products sold in approximately 125 countries. The company is led by Chair and CEO David A. Ricks and is listed on the NYSE under the ticker LLY. In November 2025, it became the first pharmaceutical company to reach a $1 trillion market capitalization.
The company's recent growth is driven by key products such as Mounjaro for diabetes and Zepbound for obesity, which generated $11.5 billion and $4.9 billion respectively in 2024. Other notable medicines in its portfolio include Verzenio, Trulicity, Taltz, Jardiance, and Kisunla for Alzheimer's. In 2024, the company reported full-year revenue of $45.04 billion.
To support its scale, Eli Lilly is undergoing major manufacturing expansions across the United States, including sites in Houston, Virginia ($5 billion), Pennsylvania ($3.5 billion), and an API site in Lebanon, Indiana.